2024 |
BeiGene Ltd - ADR
|
Independent Director |
644.1 K |
- |
2024 |
Alnylam Pharmaceuticals Inc
|
Independent Director |
481.3 K |
0.1 % |
2024 |
BeiGene Ltd - ADR
|
Director |
- |
- |
2023 |
Alnylam Pharmaceuticals Inc
|
Independent Director |
481.0 K |
0.9 % |
2023 |
BeiGene Ltd - ADR
|
Independent Director |
- |
- |
2022 |
Alnylam Pharmaceuticals Inc
|
Independent Director |
476.9 K |
1.4 % |
2021 |
Alnylam Pharmaceuticals Inc
|
Independent Director |
470.2 K |
-27.7 % |
2020 |
Alnylam Pharmaceuticals Inc
|
Independent Director |
649.9 K |
- |
2019 |
Alnylam Pharmaceuticals Inc
|
Independent Director |
- |
- |
2019 |
Sanofi - ADR
|
Director and Chief Executive Officer |
- |
- |
2018 |
Sanofi - ADR
|
Director and Chief Executive Officer |
- |
- |
2017 |
Sanofi - ADR
|
Director and Chief Executive Officer |
- |
- |
2016 |
Sanofi - ADR
|
Director and Chief Executive Officer |
- |
- |
2015 |
Sanofi - ADR
|
Director and Chief Executive Officer |
- |
- |